Walsh, Jessica A.
Song, Xue
Kim, Gilwan
Park, Yujin
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Received: 8 December 2017
Revised: 15 February 2018
Accepted: 27 March 2018
First Online: 10 April 2018
Compliance with ethical standards
:
: Xue Song and Gilwan Kim are employees of Truven Health Analytics, an IBM Company, which was paid by Novartis in connection with the development of this manuscript. Yujin Park is an employee of Novartis. Jessica Walsh is a paid consultant to Novartis.